Moreover, direct application of SPARC and decorin significantly reduced PCa cell line growth by reduced Cyclin D1 and epidermal growth factor receptor (EGFR) activation, respectively (52, 53). The gene discussed is SPARC; the disease is posterior cortical atrophy.